Jessica Shen
About Jessica Shen
Jessica Shen is the Associate Digital Director at BeiGene in Shanghai, China, with over 20 years of experience in the pharmaceutical and healthcare industry.
Current Role at BeiGene
Jessica Shen currently holds the position of Associate Digital Director at BeiGene in Shanghai, China. In this role, she is likely responsible for leading digital strategy development and implementation within the company. Her responsibilities may include overseeing digital transformation projects and driving innovative solutions to enhance the company's digital presence in the healthcare sector.
Past Experience at Novartis Oncology
Jessica Shen briefly worked at Novartis Oncology as a Senior PAP Manager from 2020 to 2021 in Shanghai, China. During her three-month tenure, she would have focused on managing patient assistance programs (PAP), which are crucial for ensuring that patients have access to necessary medications. Her work likely involved coordinating with various stakeholders to optimize PAP efficiency and effectiveness.
Long-Term Role at Sanofi
Jessica Shen had an extensive career at Sanofi, where she served as a Senior Business Analysis Manager from 2002 to 2020. Over her 18 years at the company, she developed a strong foundation in business analysis within the pharmaceutical industry. Her role would have involved analyzing market trends, financial performance, and business operations to support strategic decision-making.
Educational Background
Jessica Shen studied at Shanghai Jiao Tong University, where she pursued a degree in business administration (工商管理). She attained her Bachelor's degree from this prestigious institution, equipping her with essential skills and knowledge for her career in the pharmaceutical and healthcare industry.
Industry Expertise and Transition
With over 20 years of experience in the pharmaceutical and healthcare industry, Jessica Shen has transitioned from business analysis roles to digital leadership. Her expertise includes managing patient assistance programs and leading digital transformation initiatives. She possesses a deep understanding of the Chinese healthcare market and regulatory environment, which is crucial for her current and past roles.